Starling Oncology (STLN) EBITDA (2020 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) EBITDA (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.68 Bn | 89.67 Bn | 15.19 Bn | -2.55 Bn |
| 2 | Tenet Healthcare | 22.03 Bn | 19.86 Bn | 4.45 Bn | 1.50 Bn |
| 3 | Encompass Health | 12.07 Bn | 11.93 Bn | 1.34 Bn | 33.50 Mn |
| 4 | Davita | 11.73 Bn | 11.05 Bn | 1.16 Bn | 579.00 Mn |
| 5 | Universal Health Services | 10.15 Bn | 10.01 Bn | 3.29 Bn | 516.68 Mn |
| 6 | Ensign | 9.95 Bn | 9.63 Bn | 306.24 Mn | 122.50 Mn |
| 7 | Chemed | 6.91 Bn | 6.87 Bn | 221.47 Mn | 103.47 Mn |
| 8 | Pacs | 6.68 Bn | 6.51 Bn | 338.46 Mn | 109.33 Mn |
| 9 | Concentra Group Holdings Parent | 4.30 Bn | 4.14 Bn | 192.10 Mn | 115.07 Mn |
| 10 | Starling Oncology | 613.04 Mn | 571.94 Mn | 27.17 Mn | -3.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.49 Mn |
| Mar 31, 2026 | -5.61 Mn |
| Dec 31, 2025 | -5.99 Mn |
| Sep 30, 2025 | -7.05 Mn |
| Jun 30, 2025 | -10.18 Mn |
| Mar 31, 2025 | -8.90 Mn |
| Dec 31, 2024 | -11.00 Mn |
| Sep 30, 2024 | -13.05 Mn |
| Jun 30, 2024 | -15.62 Mn |
| Mar 31, 2024 | -17.26 Mn |
| Dec 31, 2023 | -14.48 Mn |
| Sep 30, 2023 | -13.01 Mn |
| Jun 30, 2023 | -14.34 Mn |
| Mar 31, 2023 | -32.33 Mn |
| Dec 31, 2022 | -24.62 Mn |
| Sep 30, 2022 | -19.70 Mn |
| Jun 30, 2022 | -17.95 Mn |
| Mar 31, 2022 | -18.16 Mn |
| Dec 31, 2021 | -40.57 Mn |
| Sep 30, 2021 | -1.93 Mn |